Treatment of Mycobacterium avium–intracellulare complex lung disease in the real world: a retrospective big data analysis
- 11 November 2019
- journal article
- research article
- Published by Springer Nature in Drugs & Therapy Perspectives
- Vol. 36 (2) , 75-82
Abstract
No abstract availableKeywords
Funding Information
- The Japan Society for the Promotion of Science (17K17816)
This publication has 14 references indexed in Scilit:
- British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)Thorax, 2017
- Tuberculosis hospitalization expenditures per patient from private health insurance claims data, 2010–2014The International Journal of Tuberculosis and Lung Disease, 2017
- Poor adherence to management guidelines in nontuberculous mycobacterial pulmonary diseasesEuropean Respiratory Journal, 2016
- Epidemiology of Pulmonary Nontuberculous Mycobacterial Disease, Japan1Emerging Infectious Diseases, 2016
- Diagnosis and Treatment of Nontuberculous Mycobacterial Lung DiseaseJournal of Korean Medical Science, 2016
- Diagnosis and Treatment of Nontuberculous Mycobacterial Lung Disease: Clinicians' PerspectivesTuberculosis and Respiratory Diseases, 2016
- Lack of Adherence to Evidence-based Treatment Guidelines for Nontuberculous Mycobacterial Lung DiseaseAnnals of the American Thoracic Society, 2014
- An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial DiseasesAmerican Journal of Respiratory and Critical Care Medicine, 2007
- The Microbiological and Clinical Effects of Combined Therapy according to Guidelines on the Treatment of Pulmonary Mycobacterium avium Complex Disease in Japan – Including a Follow-Up StudyRespiration, 2006
- Identification of mutations in 23S rRNA gene of clarithromycin-resistant Mycobacterium intracellulareAntimicrobial Agents and Chemotherapy, 1994